A Single Arm, Open Label Study of the Safety, Efficacy, and Pharmacokinetics of SPRIX (intranasal ketorolac tromethamine) in 0 to 11 year-Old Patients Undergoing Open Surgical Procedures

Trial Profile

A Single Arm, Open Label Study of the Safety, Efficacy, and Pharmacokinetics of SPRIX (intranasal ketorolac tromethamine) in 0 to 11 year-Old Patients Undergoing Open Surgical Procedures

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs Ketorolac (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions; Pharmacokinetics; Registrational
  • Sponsors Egalet; Luitpold Pharmaceuticals
  • Most Recent Events

    • 15 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 17 Nov 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
    • 07 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top